Cannabis Wheaton (TSX: CBW.V) (OTC: KWFLF) is a newly traded Canadian cannabis company that has received significant coverage since it started trading due its management team and differentiated strategy.

Although the company is focused on cannabis production, it does not actually produce cannabis. Cannabis Wheaton invests and partners with licensed Canadian medical cannabis companies that are in various stages of the licensing process.

Cannabis Wheaton’s streaming partners include 14 companies in six provinces across Canada. Of these companies, 2 have sales licenses (Broken Coast and Green Relief), 3 have cultivation licenses, 3 have affirmation letters and 6 are advanced pre-affirmation stage applicants. Through these agreements, Cannabis Wheaton has access to 1.3 million square feet of cultivation by 2019.

Beleave: First Streaming Partner to Receive Cultivation License

One of its streaming partners, Beleave (BLEVF) (BE.CN: CSE) issued a corporate update earlier today which reported some significant developments. This comes only days after Beleave was awarded a cultivation license from Health Canada.

Earlier this month, the companies signed an agreement where Cannabis Wheaton will finance a second production facility for Beleave in return for equity in a joint venture company and a production yield allocation from the new facility.

The cultivation license significant a milestone for both Beleave and Cannabis Wheaton. While it is more significant for Beleave, it is first streaming partner to advance in Health Canada’s licensing process. This is a trend that we expect to continue to occur for Cannabis Wheaton’s streaming partners over the coming months.

Artiva: An Early Stage Opportunity

Another holding within Cannabis Wheaton’s portfolio is Artiva, an advanced pre-affirmation stage applicant. The company is a subsidiary of LiveWell which is a leading Canadian cannabis and functional food business.

Click here to view the full article.